Fingerprint
Dive into the research topics of 'Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
CheckMate 9ER Investigators
Research output: Contribution to journal › Article › peer-review
909
Scopus
citations